Nasdaq auph.

Aug 15, 2022 · The fact that multiple Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When ... Nasdaq provides company’s , which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all publicly ...Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)’s traded shares stood at 0.69 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $9.28, to imply an increase of 2.66% or $0.24 in intraday trading.Dec 4, 2023 · December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session. Dec 1, 2023 · AUPH Stock Overview. Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. About the company. AUPH fundamental analysis.

Aurinia Pharmaceuticals Inc. (AUPH) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 9.06 +0.42 (+4.86%) At close: 04:00PM EST 8.94 -0.12 ( …

Halt Date, Halt Time, Issue Symbol, Issue Name, Market, Reason Codes, Pause Threshold Price, Resumption Date, Resumption Quote Time, Resumption Trade Time.Aurinia Pharmaceuticals (NASDAQ: AUPH), in its third-quarter earnings call for 2023, reported a significant increase in net product revenue and ongoing expansion efforts, while also revealing that ...

Aurinia Pharmaceuticals AUPH rose almost 5.8% on Jun 30, as management announced that it is exploring strategic alternatives for the company’s future. AUPH will consider a range of options ...Jun 30, 2023 · Aurinia Pharmaceuticals (NASDAQ:AUPH) could see prices in the high $20s to low $30s per share in a takeout at premium multiples, according to RBC, after the company announced Thursday it was ... Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals — Discovering Underlying ...Dr_Microbe. This article is a follow-up to my previous coverage of Aurinia Pharmaceuticals (NASDAQ:AUPH) and as such may run a little shorter than earlier ones.In particular, today, I'd like to ...Aurinia Pharmaceuticals ( NASDAQ: AUPH) rose 5% in regular trading as two board members, including the chairman, resigned from the board after receiving less than majority support in a shareholder ...

Aurinia Pharma (NASDAQ: AUPH) shares quickly jumped to a session high, triggering a volatility halt after Bloomberg reported a potential bid from Bristol Myers Squibb (NYSE: BMY) to acquire the ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH): Supportive interim analysis of its AURORA 2 Phase 3 continuation study that is evaluating Lupkynis for the treatment of lupus nephritis.

Nov 24, 2023 · Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)’s traded shares stood at 0.69 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $9.28, to imply an increase of 2.66% or $0.24 in intraday trading. AUPH Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 19:59:23. $9.37. 100. Get the latest Aurinia Pharmaceuticals Inc (AUPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher, adding to gains of more than 17% over the last week.Aurinia Pharmaceuticals (NASDAQ:AUPH) recently announced they have reached a settlement with Sun Pharmaceuticals (OTCPK:SMPQY) to dismiss their claims and counterclaims against each other.Losses were broad based as all sectors finished the trading session in red. WallStEquities.com has initiated research reports on the following Biotechnology stocks: Intra-Cellular Therapies Inc ...Avid Bioservices Inc (NASDAQ:CDMO)’s Major holders. Insiders own 0.82% of the company shares, while shares held by institutions stand at 108.12% with a share float percentage of 109.02%. Investors are also buoyed by the number of investors in a company, with Avid Bioservices Inc having a total of 253 institutions that hold shares in the company.

July 15, 2020 at 10:15 AM · 4 min read. Steven Cohen ( Trades, Portfolio ), head of Point72 Asset Management, disclosed this week his firm upped its stake in Otonomy Inc. (NASDAQ:OTIC) by 1,354. ...2 нояб. 2023 г. ... Aurinia Pharmaceuticals (AUPH) reported better-than-expected Q3 2023 financials on Thursday driven by its lupus nephritis therapy Lupkynis.The new research reports from Market Source Research, available for free download at the links above, examine Haverty Furniture Companies, Inc. (NYSE:HVT), BLACKLINE INC (NASDAQ:BL), MagnaChip ...Below is a chart showing AUPH's trailing twelve month trading history, with the $9 strike highlighted in orange: Phillips 66 (Symbol: PSX) options are showing a volume of 21,547 contracts thus far ...2 analysts have issued twelve-month price targets for Aurinia Pharmaceuticals' stock. Their AUPH share price targets range from $13.00 to $15.00. On average, they expect the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 62.8% from the stock's current price. View analysts price targets for AUPH or ...Aurinia Pharmaceuticals Inc stock price (AUPH) NASDAQ: AUPH. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Aurinia Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

Price. 9.04. Webull offers AUPH Ent Holdg (AUPH) historical stock prices, in-depth market analysis, NASDAQ: AUPH real-time stock quote data, in-depth charts, free AUPH …

Find the latest dividend history for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) at Nasdaq.com.About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.AUPH Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. ...Feb 28, 2022 · What happened. Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are poised for a tough session today. Ahead of the opening bell, the drugmaker's share price ... As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.Real time Aurinia Pharmaceuticals (AUPH) stock price quote, stock graph, news & analysis. EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the third ...Get the latest Aurinia Pharmaceuticals Inc (AUPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.October 30, 2023 at 7:26 AM · 3 min read We feel now is a pretty good time to analyse Aurinia Pharmaceuticals Inc.'s ( NASDAQ:AUPH) business as it appears the company …

Feb 28, 2022 · What happened. Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are poised for a tough session today. Ahead of the opening bell, the drugmaker's share price ...

Swiss National Bank raised its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 7.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).The firm owned 279,300 shares of the biotechnology company’s stock after acquiring an …

jurgenfr. Canadian biotech Aurinia Pharmaceuticals ( NASDAQ: AUPH) lost ~22% pre-market Thursday even after announcing better-than-expected financials for Q3 2022 as the company lowered its full ...NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on ...May 22, 2023 · Last month, AUPH's second largest shareholder, MKT Capital, which holds 4.2% of the stock, wrote a scathing letter to shareholders, calling to withdraw support for CEO Peter Greenleaf, board ... AUPH Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.20 with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 71.29% change from the last price of $8.29.Jan 5, 2023 · Aurinia Pharmaceuticals (NASDAQ:AUPH) recently announced they have reached a settlement with Sun Pharmaceuticals (OTCPK:SMPQY) to dismiss their claims and counterclaims against each other. AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.At Aurinia, we embrace the possibility to change the trajectory of autoimmune diseases with unmet needs. With a growing pipeline and a dynamic team of proven experts, our work is patient-centric and driven by a sense of urgency. See how we are poised to deliver on our mission. Learn More.NEW YORK, May 29, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...

Real time Aurinia Pharmaceuticals (AUPH) stock price quote, stock graph, news & analysis. Aurinia’s (NASDAQ:AUPH) price movement over the last 12 months seems predicated on 3 things - key management changes, lackluster lupkynis sales, and most importantly, discontinuous whispers of M ...The new research reports from Fundamental Markets, available for free download at the links above, examine Shinhan Financial Group Co Ltd (NYSE:SHG), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH ...Instagram:https://instagram. energy stock priceday trade scannersfunding trading companiesvanguard growth index funds Shares of NASDAQ AUPH opened at $9.06 on Monday. The company has a current ratio of 5.77, a quick ratio of 5.33 and a debt-to-equity ratio of 0.18. Aurinia Pharmaceuticals Inc. has a twelve month low of $4.07 and a twelve month high of $12.43. The stock has a 50 day moving average of $7.93 and a two-hundred day moving average of $9.20.Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. solar power companies stocksandp 500 highest Anyone who held Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) over the last year knows what a loser feels like. The share price has slid 66% in that time. The share price has slid 66% in that time. autozonr The new research reports from Fundamental Markets, available for free download at the links above, examine B Communications Ltd. (NASDAQ:BCOM), Student Transportation Inc (NASDAQ:STB), Aurinia ...Below is a chart showing AUPH's trailing twelve month trading history, with the $9 strike highlighted in orange: Phillips 66 (Symbol: PSX) options are showing a volume of 21,547 contracts thus far ...